Medtronic Finalizes Exchange Offer Terms: 225M MiniMed Shares at 7% Discount, $1.7B Expected Gain
MMED sits 88% above its 52-week low of $10.65 on elevated volume (7.2× avg).
Summary
Medtronic's exchange offer to divest up to 80.1% of MiniMed is now fully specified: 225.4M shares at a 7% discount to MiniMed's VWAP, expiring October 9, 2026, with Medtronic expecting a ~$1.7B pre-tax gain.
Key Events · M&A and Partnerships · MMED
-
Exchange Offer Terms Finalized
Medtronic offers up to 225,361,295 newly issued MiniMed shares for Medtronic ordinary shares at a 7% discount to MiniMed's three-day VWAP, subject to an upper limit of 4.5939 shares per Medtronic share. Offer expires October 9, 2026.
-
De Minimis Increase and Minimum Amount
If oversubscribed, Medtronic may accept up to 27,452,053 additional MiniMed shares (its entire remaining stake) for up to 5,975,762 additional Medtronic shares. Minimum condition: at least 112,680,647 MiniMed shares (50% of offer) must be issued.
-
Expected $1.7B Pre-Tax Gain for Medtronic
Based on September 11, 2026 closing prices ($90.96 MDT, $22.50 MMED), Medtronic expects to recognize a pre-tax gain of approximately $1.7 billion. Each $1.00 increase in MiniMed's share price would add approximately $230 million to the gain.
-
60-Day Lock-Up on Remaining MiniMed Shares
Medtronic agreed not to sell any remaining MiniMed shares for 60 days after the offer expires (through approximately December 8, 2026), subject to dealer manager consent.
Analysis · MMED · Industrial Applications And Services
This prospectus finalizes the mechanics of Medtronic's split-off of MiniMed, first announced September 14. The exchange ratio is now fully specified: Medtronic shareholders receive approximately $107.53 of MiniMed stock for each $100 of Medtronic shares tendered, subject to an upper limit of 4.5939 shares per Medtronic share. The offer expires October 9, 2026, with the averaging period running October 5-7. Medtronic expects to recognize a pre-tax gain of approximately $1.7 billion on the transaction. The deal will distribute up to 225.4 million newly issued MiniMed shares — roughly 80% of the company — to Medtronic shareholders, transforming MiniMed's shareholder base and float. A 60-day lock-up on Medtronic's remaining MiniMed shares runs through approximately December 8, 2026.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MMED was trading at $20.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $10.65 to $24.43. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.